De NovoDonor-Specific HLA Antibodies Are Associated With Rapid Loss of Graft Function Following Islet Transplantation in Type 1 Diabetes

Attainment of Metabolic Goals in the Integrated UK Islet Transplant Program With Locally Isolated and Transported Preparations

(2013) A. M. Brooks et al.   AMERICAN JOURNAL OF TRANSPLANTATION

Pretransplant identification of acute rejection risk following kidney transplantation

(2013) Yvon Lebranchu et al.   TRANSPLANT INTERNATIONAL

Predictive Factors of Allosensitization After Immunosuppressant Withdrawal in Recipients of Long-Term Cultured Islet Cell Grafts

(2013) Robert Hilbrands et al.   TRANSPLANTATION

Preformed andDe NovoDonor Specific Antibodies in Visceral Transplantation: Long-Term Outcome With Special Reference to the Liver

(2012) K. M. Abu-Elmagd et al.   AMERICAN JOURNAL OF TRANSPLANTATION

Alloantibody and Autoantibody Monitoring Predicts Islet Transplantation Outcome in Human Type 1 Diabetes

(2012) L. Piemonti et al.   DIABETES

Improvement in Outcomes of Clinical Islet Transplantation: 1999-2010

(2012) F. B. Barton et al.   DIABETES CARE

HLA Class I Sensitization in Islet Transplant Recipients: Report from the Collaborative Islet Transplant Registry

(2011) Bashoo Naziruddin et al.   CELL TRANSPLANTATION

Evidence for Induced Expression of HLA Class II on Human Islets: Possible Mechanism for HLA Sensitization in Transplant Recipients

(2010) Andrew M. Jackson et al.   TRANSPLANTATION

De NovoDonor-Specific Antibody at the Time of Kidney Transplant Biopsy Associates with Microvascular Pathology and Late Graft Failure

(2009) L. G. Hidalgo et al.   AMERICAN JOURNAL OF TRANSPLANTATION

Low Risk of Anti-Human Leukocyte Antigen Antibody Sensitization After Combined Kidney and Islet Transplantation

(2009) Sylvie Ferrari-Lacraz et al.   TRANSPLANTATION

Cellular Islet Autoimmunity Associates with Clinical Outcome of Islet Cell Transplantation

(2008) Volkert A. L. Huurman et al.   PLoS One